Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Rosen BC, Mauter JT, Voigt TB, de Figueiredo Godoy G, Walker EL, Louw JJ, Ghosh N, Panayiotou C, Yrizarry-Medina A, Terao J, Rakasz EG, Reynolds MR, Dudley DM, Reed DS, Watkins DI, Ricciardi MJ. Elicitation of Potent H5N1- and H7N9-Neutralizing Antibody Responses in Rhesus Macaques by Sequential Heterologous Vaccination with mRNA and Adenoviral Vectors Encoding Full-Length Hemagglutinins. Viruses. 2026 09 07; 18(9).
-
DiLillo KM, Forconi CS, Matta A, Melo J, McNamara RP, Tonui R, N'juguna F, Otieno JA, Odwar B, Kinyua A, Lauffenburger DA, Moormann AM. Estimating SARS-CoV-2 exposure in asymptomatic hospitalized children with cancer in Western Kenya: A retrospective analysis of serological data. PLoS One. 2026; 21(7):e0353284.
-
Voigt TB, Ghosh N, Rosen BC, Newbolt T, Louw JJ, Yrizarry-Medina A, Panayiotou C, Mauter JT, de Figueiredo Godoy G, Terao J, Rakasz EG, Reynolds MR, Dudley DM, Watkins DI, Ricciardi MJ. Heterologous Sequential mRNA Vaccination of Indian Rhesus Macaques Elicits Broad Binding and Neutralizing Antibody Responses Against Diverse Henipaviruses. Viruses. 2026 Apr 23; 18(5).
-
Nguyen TVH, Vu ND, Nguyen VD, Than TT, Dang TN, Nguyen HT, Tran TCG, Nguyen HT, Nguyen PA, Cho KH, Hong SK, Ambagala A, Kim YH, Le VP. Pathobiological characterization and estimation of the basic reproduction number of a recombinant african swine fever virus in contact-exposed pigs in Vietnam. Vet Microbiol. 2026 May; 316:110961.
-
Golonka RM, Intravaia LE, Shaqra AM, Li Q, Chen Y, Humphries F, Kurt-Yilmaz N, Fitzgerald KA, Schiffer CA, Wang Y, Cavacini LA. Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potential. J Biol Chem. 2026 Mar; 302(3):111210.
-
Fitz-Patrick D, McVinnie DS, Jackson LA, Crowther G, Geevarughese A, Cannon KD, Garcia LM, Pineiro Puebla Y, Yi Z, Cunliffe L, Maniar A, Zareba AM, Ianos CA, Gomme E, Koury K, Suphaphiphat Allen P, Anderson AS, Gurtman A, Lindert K. Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine. N Engl J Med. 2025 Nov 20; 393(20):2001-2011.
-
Ding S, Yang D, Ullah I, Niu L, Unger M, Díaz-Salinas MA, Chandravanshi M, Zhou F, Beaudoin-Bussières G, Benlarbi M, Tolbert WD, Yoon K-W, Xu R, Laroche G, Gaudette F, Morton AJ, Lang ZC, Son A, Abrams C, Côté M, Smith AB, Huang RK, Matthies D, Munro JB, Pazgier M, Uchil PD, Finzi A. Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants. J Virol. 2025 11 25; 99(11):e0103425.
-
Almeida GG, Pinto JA, Pinto PM, da Silva LB, Andrade LAF, Valiate BVS, Zini N, Bagno FF, Rivelli GG, Lourenço KL, Souza JPC, Gomes IP, de Castro NS, Maia ALC, de Carvalho AF, Alves JC, de Castro JT, Li G, da Rocha Fernandes G, Alves PA, Diniz RC, Daher AB, de Souza RP, Teixeira SMR, Fernandes APSM, Gazzinelli RT, da Costa Santiago H. Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19. Vaccine. 2025 Oct 03; 64:127756.
-
Dasan B, Munisankar S, Kumar NP, Moideen K, Pandiarajan AN, Nott S, Viswanathan V, Shanmugam S, Hissar S, Thiruvengadam K, Kornfeld H, Babu S. Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosis. Front Immunol. 2025; 16:1612709.
-
Cardoso KF, de Souza LRA, Martins DS, da Silva Santos BSÁ, de Carvalho KRA, da Silva Messias SG, de Faria Gonçalves AP, Do Nascimento Macário RR, de Jesus DJF, De Mendonça Ângelo ALP, de Paula Pereira L, Nascimento SLM, Kano FS, Alves PA, Xavier MAP, Martins-Filho OA, Russo RC, Gazzinelli RT, Miyaji EN, Garcia CC, de Magalhães Vieira Machado A, Araújo MSS. Safety and efficacy of an intramuscular bivalent vaccine against influenza and Streptococcus pneumoniae infections in mice. Med Microbiol Immunol. 2025 Aug 29; 214(1):39.